Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion type Assertion NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_head.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion description "[protein), but the AR binding affinity (Kd) for DHT is only 25 nM, approximately 50-fold lower affinity than the mutated AR in LNCaP prostate cancer cells (Kd = 0.5 nM) or the wildtype AR in MCF-7 breast cancer cells (Kd = 0.4 nM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_provenance.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion evidence source_evidence_literature NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_provenance.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion SIO_000772 10569618 NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_provenance.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion wasDerivedFrom befree-2016 NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_provenance.
- NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_assertion wasGeneratedBy ECO_0000203 NP268095.RA2jEFkE_bE-UDgvYaLiUj1Hv1pmn8rEG2ZKulsLwzdy0130_provenance.